Article Information
History
- June 20, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yumeko Kawano1,2,
- Naomi J. Patel2,3,
- Xiaosong Wang1,
- Claire E. Cook3,
- Kathleen M.M. Vanni1,
- Emily N. Kowalski1,
- Emily P. Banasiak1,
- Grace Qian1,
- Michael DiIorio2,4,
- Tiffany Y. T. Hsu1,2,
- Michael E. Weinblatt1,2,
- Derrick J. Todd1,2,
- Zachary S. Wallace2,3,5,* and
- Jeffrey A. Sparks1,2,*,#
- 1Division of Rheumatology, Inflammation, and Immunity, Brigham and Women’s Hospital, Boston, MA, USA
- 2Harvard Medical School, Boston, MA, USA
- 3Division of Rheumatology, Allergy, and Immunology, Massachusetts General Hospital, Boston, MA, USA
- 4Department of Medicine, Brigham and Women’s Hospital, Boston, MA, USA
- 5Clinical Epidemiology Program, Mongan Institute, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
- ↵#Corresponding author: Jeffrey A. Sparks, MD, MMSc, Division of Rheumatology, Inflammation, and Immunity Brigham and Women’s Hospital, 60 Fenwood Road, #6016U Boston, MA 02115, 617-525-1040, jsparks{at}bwh.harvard.edu, @jeffsparks
↵* ZSW and JAS contributed equally and are co-senior authors.
Posted June 20, 2022.
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: From the first wave to Omicron
